Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
UMC Utrecht
Blokhin's Russian Cancer Research Center
Barbara Ann Karmanos Cancer Institute
University of Nebraska
Var2 Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Columbia University
Tempus AI
Stanford University
Taproot Health
Leiden University Medical Center
Eastern Cooperative Oncology Group
Aarhus University Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
SpeciCare
Stanford University
Swiss Cancer Institute
CureOne
Maastricht Radiation Oncology
Stanford University
Leaf Vertical Inc.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center